Watchlist Price Alert

BioRestorative Therapies ... (BRTX)

NASDAQ: BRTX · Real-Time Price · USD

1.55

-0.04 (-2.52%)

At close: Jul 03, 2025, 2:45 PM

1.59

2.58%

After-hours: Jul 03, 2025, 02:45 PM EDT

BioRestorative Therapies Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	401K	145.8K	119.8K	46K	77K	130K	111K	81K	36.35K
Cost of Revenue	28.07K	165.74K	280.67K	205.21K	n/a	n/a	n/a	259.26K	102.00
Gross Profit	372.93K	-19.93K	-160.87K	-159.21K	77K	130K	111K	-178.26K	36.25K
Operating Income	-11.56M	-15.22M	-18.97M	-26.31M	-2.75M	-8.43M	-7.65M	-8.37M	-7.8M
Interest Income	616.08K	552.29K	11.65K	1.82M	1.64M	5.14M	n/a	n/a	n/a
Pretax Income	-8.98M	-10.42M	-18.49M	-44.3M	-11.27M	-14.65M	-12.52M	-9.44M	-8.64M
Net Income	-8.98M	-10.42M	-18.02M	-29.94M	-12.25M	-17.92M	-12.52M	-9.44M	-8.64M
Selling & General & Admin	6.58M	11.33M	15.58M	25.62M	1.95M	6.84M	6.25M	6.3M	4.95M
Research & Development	5.35M	4.03M	3.51M	729.06K	876.83K	1.72M	1.51M	2.15M	2.88M
Other Expenses	n/a	n/a	-110.52K	-16.18M	-658.15K	-1.87M	-1.42M	-59.94K	-46.6K
Operating Expenses	11.93M	15.2M	18.98M	26.35M	2.83M	8.56M	7.76M	8.46M	7.83M
Interest Expense	n/a	n/a	11.65K	1.82M	1.64M	5.14M	3.22M	1.09M	763.94K
Selling & Marketing Expenses	n/a	168.03K	n/a	12.29K	28.28K	321.28K	352.2K	65.45K	86.45K
Cost & Expenses	11.96M	15.37M	18.98M	26.35M	2.83M	8.56M	7.76M	8.46M	7.83M
Income Tax Expense	n/a	n/a	-479.26K	-14.36M	981.99K	3.27M	-1.65M	1.03M	717.34K
Shares Outstanding (Basic)	7.76M	4.22M	3.62M	1.19M	394.7K	5.57K	2.93K	1.53K	1.17K
Shares Outstanding (Diluted)	7.76M	4.22M	3.62M	1.19M	394.7K	5.57K	2.93K	1.53K	1.17K
EPS (Basic)	-1.16	-2.47	-4.98	-25.21	-31.05	-3.22K	-4.27K	-6.18K	-7.36K
EPS (Diluted)	-1.16	-2.47	-4.98	-25.21	-31.05	-3.22K	-4.27K	-6.18K	-7.36K
EBITDA	-11.37M	-15.06M	-18.85M	-26.22M	-9.48M	-9.29M	-9.06M	-8.1M	-7.61M
EBIT	-11.56M	-10.42M	-18.97M	-26.31M	-9.63M	-9.51M	-9.3M	-8.36M	-7.87M
Depreciation & Amortization	189.06K	165.74K	120.54K	205.21K	151.96K	217.45K	240.37K	259.26K	258.43K